'FDA' Category
By Simmons Hanly Conroy | January 27, 2012
All FDA Committee Members Should Get to Speak Out Regarding Yaz
In a previous blog post, we shared a news story regarding the FDA and the recent Yaz, Yasmin vote that has come under scrutiny. Is the FDA in bed with big pharmaceutical companies?… Read More
By Simmons Hanly Conroy | January 20, 2012
FDA’s Recent Yaz, Yasmin Vote Under Scrutiny
A recent MedPage Today article printed in EveryDay Health* reports that four FDA medical advisors voting on the risks versus benefits of birth control medications, like Yaz and Yasmin, had ties to Bayer. These FDA… Read More
By Simmons Hanly Conroy | June 3, 2011
FDA to Review Popular Birth Control Pill Yaz
Women who take birth control know doing so comes with a risk of blood clots, especially if they’re a smoker over 35. However, two new studies by the British Medical Journal found that women… Read More
By Simmons Hanly Conroy | June 1, 2011
Health Risks Underestimated for Popular Smoking-Cessation Drug Chantix
A Pharmaceutical watch dog group has reported that the risks of smoking cessation drug Chantix (Varenicline) have been underestimated in the latest round of the Food & Drug Administration reporting. The Institute for… Read More
By Simmons Hanly Conroy | May 24, 2011
Avandia Pulled From Shelves Months After Dangers Known
The Food & Drug Administration announced last week that it will pull the diabetes drug Avandia and its sister medications Avandamet and Avandaryl from retail pharmacy shelves beginning in November. After Nov. 18, only certified… Read More
By Simmons Hanly Conroy | November 24, 2010
FDA Pulls Darvon, Darvocet from Market for Heart Risks
The maker of the pain killer medicine known as Darvon and Darvocet, or propoxyphene, announced last week it will stop making the popular drugs because it can cause serious heart rhythm abnormalities,… Read More
By Simmons Hanly Conroy | September 1, 2010
New Study Warns Meridia Weight Loss Pill Increases Heart Attack, Stroke Risk
People with heart disease who want to lose weight should avoid taking Abbott’s weight loss pill Meridia, according to a new study funded by the drug’s manufacturer. In Europe, the drug, known… Read More
By Simmons Hanly Conroy | July 18, 2010
Avandia Stays on Market Despite Heart Attack Dangers
In a puzzling turn of events this week, an F.D.A. panel voted 20-12 to leave Avandia, from GlaxoSmithKline, on the market but with restrictions because of heart attack risks. Avandia was once the… Read More
By Simmons Hanly Conroy | June 4, 2010
Antacid drugs linked to increased risk of bone fractures, FDA warns
Take a pill for heartburn and you could fracture a bone. While it won’t happen overnight, the FDA released a warning last week informing consumers that long-term use of such drugs, known as proton… Read More
By Simmons Hanly Conroy | May 26, 2010
Simmons Hanly Conroy Monitors Tylenol Recalls, FDA Investigation
Due to reports of serious side effects, McNeil, a division of Johnson & Johnson, has made four major recalls of over-the-counter products, including Tylenol, Motrin and Benadryl, in the past seven months.… Read More
